tiprankstipranks
Trending News
More News >

Akoya Biosciences price target lowered to $1.65 from $2.40 at Piper Sandler

Piper Sandler analyst David Westenberg lowered the firm’s price target on Akoya Biosciences (AKYA) to $1.65 from $2.40 and keeps a Neutral rating on the shares following quarterly results. The firm cites lower expected capital expenditures.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1